| |
| Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands |
| Meijboom MJ, Rozenbaum MH, Benedictus A, Luytjes W, Kneyber MC, Wilschut JC, Hak E, Postma MJ |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Meijboom MJ, Rozenbaum MH, Benedictus A, Luytjes W, Kneyber MC, Wilschut JC, Hak E, Postma MJ. Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands. Vaccine 2012; 30(31): 4691-4700 Indexing Status Subject indexing assigned by NLM MeSH Cost-Benefit Analysis; Decision Support Techniques; Humans; Infant; Models, Economic; Netherlands; Quality-Adjusted Life Years; Respiratory Syncytial Virus Infections /prevention & Respiratory Syncytial Virus Vaccines /economics; Vaccination /economics; control AccessionNumber 22012023897 Date bibliographic record published 22/01/2013 |
| |
|
|
